SKN | Amaero Revives Nasdaq IPO Plans With $20 Million Offering After Cutting Deal Size 62%
Amaero, an Australian-listed producer of titanium and refractory metal powders for defense, aerospace and 3D printing applications, has revived its plans for a U.S....
SKN | Biotech IPOs Show Resilience as Retension and TRex Target Nasdaq
Key Points:
Retension Pharmaceuticals and TRex Bio are positioned to bring roughly $176 million of potential gross IPO value to Nasdaq, making biotechnology the...
SKN | Iambic Therapeutics Sets Terms for $150 Million IPO to Advance AI-Driven Cancer Drugs
Key Points:
Iambic Therapeutics plans to raise $150 million by offering 9.4 million shares at $15 to $17 each, implying a fully diluted market...
SKN | Centinel Spine Files for $100 Million IPO to Advance Motion-Preserving Spinal Implants
Centinel Spine Holdco, a medical device company developing total disc replacement implants for the cervical and lumbar spine, has filed with the U.S. Securities...
SKN | Braze, Inc. Expands Customer Engagement Platform as AI Reshapes Marketing Technology
Braze, Inc. is an established public software company rather than a new IPO candidate, so the Vittoria-specific $8 million fundraising target, revised offering size...